Patient and tumor characteristics according to the adjuvant treatment protocol
| Patient characteristics | All patients n (%) | RT n (%) | ChT and RT n (%) | P values |
| Patient age | ||||
| <60 years | 40 (44) | 13 (41) | 27 (45) | 0.4 |
| ≥60 years | 52 (57) | 19 (59) | 33 (55) | |
| Pathology | ||||
| Non-endometrioid | 26 (28) | 19 (32) | 7 (22) | 0.2 |
| Endometrioid | 66 (72) | 41 (68) | 25 (78) | |
| LVSI | ||||
| Present | 64 (70) | 23 (72) | 41 (68) | 0.5 |
| Absent | 14 (15) | 3 (9) | 11 (18) | |
| Unknown | 14 (15) | 6 (19) | 8 (14) | |
| Myometrial invasion | ||||
| <50% | 18 (20) | 5 (16) | 13 (22) | 0.2 |
| ≥50% | 63 (68) | 22 (68) | 41(68) | |
| Unknown | 11 (12) | 5 (16) | 6 (10) | |
| No of PA ln metastasis | ||||
| 1 | 40 (44) | 11 (34) | 29 (48) | 0.3 |
| >1 | 52 (56) | 21 (66) | 31 (52) | |
| Grade | ||||
| I | 18 (20) | 6 (19) | 12 (22) | 0.8 |
| II | 23 (25) | 7 (22) | 16 (27) | |
| III | 51 (55) | 19 (59) | 32 (53) | |
| Vaginal BRT | ||||
| Yes | 58 (63) | 35 (58) | 23 (72) | 0.1 |
| No | 34 (37) | 25 (42) | 9 (28) |
BRT, brachytherapy; ChT, chemotherapy; LVSI, lymphovascular space invasion; PA, paraaortic; RT, radiotherapy.